Chile's first cannabis-based medicine goes on sale
Cannabiol, the first cannabis-based medicine developed in Chile, has been put up for sale This week in a municipal pharmacy north of Santiago. It is designed to treat chronic pain resulting from neurological diseases or cancer.
Chile legalized medical cannabis in 2015, and was content until now to import its medical cannabis. In 2016, Sativex was also approved for sale.
Cannabiol was developed by a Chilean laboratory specializing in phytotherapy, Knop Laboratories, after obtaining a special permit from the Institut de Santé Publique (ISP) to distribute the drug.
The cannabis used in the production of this medicine comes from the 6,900 plants of the «Tierra Santa» plantation, in the town of Quinamávida (about 350 km south of Santiago), which belong to the Fundación Daya, which advocates the medical use of cannabis.
The Foundation has partnered with 15 municipalities to distribute the drug. Approximately 2,500 people in these towns will have access to Cannabiol, and a further 200 people have registered for PSI authorization.
Presented in oily form, it sells for 75$ per 30 mL.
In Chile, although private consumption is authorized, the sale of cannabis is still punishable. The Chilean Congress is currently debating a bill to regulate the consumption and self-cultivation of cannabis.
-
Business2 weeks ago
The legal cannabis market in New York exceeds 4 billion $ in revenue
-
Cannabis in France3 weeks ago
Which countries legalized medical cannabis before France?
-
Business3 weeks ago
South Korea is preparing to begin local production of medical cannabis to meet rising demand
-
Cannabis in Thailand3 weeks ago
From the boom in dispensaries to a purely medical approach: Thailand is revising its cannabis policy
-
Cannabis and driving3 weeks ago
Medical Cannabis and Driving: New South Wales Ends Automatic Penalties for THC
-
Cannabis in Argentina4 weeks ago
Argentina Opens Its Market to Hemp Flowers Containing 1% of THC
-
Autism3 weeks ago
Autism and Cannabis: Results from the First Placebo-Controlled Trial of NTI164
-
Cannabis in France2 weeks ago
France’s Drug Policy Chief Defends Cannabis Prohibition... and Runs Into the Facts


You must be logged in to post a comment Login